Crystal deposition in asymptomatic knee and first metatarsophalangeal (MTP) joints has been studied in 31 patients with previously proven gout. All had had clinical gout in their MTP joints but their knee joints had never been the site of acute gout. Knee arthroscopy was performed permitting synovial membrane inspection, photography and biopsy. Crystalline material was seen in 9 knees (28%) and confirmed histologically as monosodium urate (MSU) in 4 (12.5%). Synovial fluid analysis on 26 samples using a polarizing light microscope demonstrated MSU crystals in 4 (12.5%) and calcium pyrophosphate dihydrate (CPPD) in 2 (6%). Fluid aspirated from 27 of the metatarsophalangeal joints revealed MSU crystals in 14 (52%) and no CPPD crystals.
Introduction
It has been generally accepted that an acute attack of gouty arthritis is provoked by shedding or precipitation of monosodium urate (MSU) crystals into synovial fluid (McCarty & Hollander 1961) . Following resolution of the attack, MSU crystals may still be found in the synovial fluid (Zvaifler & Pekin 1963) and membrane (Zevely et al. 1956) . Recently it has been reported that previously uninvolved asymptomatic great toe metatarsophalangeal (MTP) joints may contain MSU crystals (Weinberger et al. 1979 , Rouault et al. 1982 . In this study a systematic evaluation of the great toe and knee joints of asymptomatic gouty patients has been performed.
Methods
Informed consent was obtained from 31 patients who attended Charing Cross Hospital gout clinic. All patients were male with a mean age of 61 years (range 26 to 81 years) and had previously had podagra. The mean duration of gouty history was 10 years (range 9 months to 30 years) with the mean length of time since the last attack of acute gout in any joint being two years (range one week to 20 years). None of the patients had ever had an acute attack of gout in the knee examined, although in one patient MSU crystals had been identified in fluid obtained from an enlarged popliteal cyst. At the time of study there was no evidence of inflammation in the first MTP, although all had a history of podagra.
Arthroscopy was performed in a day ward operating theatre under local anaesthetic. At arthroscopy adequate views were obtained of the anterior compartment of the knee in 30 of the 31 patients: one was abandoned because severe osteoarthritic changes obstructed a clear view. Following a thorough inspection, photographs and synovial biopsies were taken, in particular of regions containing macroscopic crystalline material.
Immediately following arthroscopy the first MTP joint was aspirated under local anaesthetic using a 24-gauge needle placed one centimetre medial to the tendon of extensor hallucis longus at a level where the joint's margins could be felt. The first MTP joint was successfully aspirated in 27/31: although the joint was not inflamed it was usually possible to obtain a drop or two of fluid. Synovial fluid collected from the knee and MTP joints was studied using a polarizing light microscope to demonstrate crystals. 'Paper read to Section of Rheumatology & Rehabilitation, 8 February 1984 . Accepted 30 April 1984 The synovial membrane biopsies were treated in two ways: some pieces were fixed in 10% buffered formalin and stained with haematoxylin and eosin; other pieces were fixed in industrial methylated spirit 99% and stained using haemotoxylin and eosin, von Kossa and Gomori methanamine and silver techniques. Results (Table 1) Crystalline material was detected in 9 out of 30 successful knee arthroscopies. Such material was observed through the arthroscope lying on the synovial membrane in 8 of the 9 cases. Microscopy of the synovial membrane biopsies obtained at each arthroscopy revealed MSU crystals in only 3 and calcium pyrophosphate dihydrate (CPPD) in one. Synovial fluid analysis of the 27 samples obtained from 31 knees demonstrated MSU crystals in 4 cases and CPPD in 2. Chondrocalcinosis was evident on plain radiograph of the knee in one of these patients. In 4 patients it was not possible to verify the nature of the crystals seen at arthroscopy as no crystals were identified in the synovial fluid or membrane. In one patient (SS) MSU crystals were present in the synovial fluid and not in the synovial membrane, and in another patient (RA) MSU crystals were confirmed at histology but no synovial fluid was obtained for analysis. In one further patient (JS) MSU crystals were identified in the synovial fluid but not seen at arthroscopy.
Analysis of the 27 joint fluids from the first MTP joint aspiration showed crystals in 14 (52%). Intra-articular MSU crystals were present in 15 patients in the first MTP or knee or both joints. In all but one patient in whom MSU crystals were verified in the knee, the first MTP joint also contained MSU crystals.
There was no significant correlation between the mean length of gouty history, or time elapsed since the last attack of acute gout, and the presence or absence of crystals. The mean serum uric acid in patients in whom crystals were demonstrated was 424.5 imol/l compared with 338.3 umol/l in the remaining 14 patients without crystals (P < 0.05). However, in patients receiving urate-lowering treatment there was no significant difference in the mean serum uric acid between those with MSU crystals (373 Mmol/l) and those without crystals (317 Mumoll). Eight patients were not taking urate-lowering treatment and in all of these crystals were identified in knee or first MTP joint (Table 2) . Twenty-three patients were receiving urate-lowering treatment; in 15 of these no MSU crystals were identified. In the remaining 8 patients on treatment, MSU crystals were demonstrated in one or both joints (X2 = 12.8, P < 0.001). In 4 of these treated patients with MSU crystals present, good control of serum uric acid was achieved ( < 350 ,umol/l).
Discussion
Monosodium urate crystals have previously been identified in quiescent knee and great toe joints in gouty patients (Weinberger et al. 1979 , Rouault et al. 1982 . It has also been reported that in sporadic cases MSU crystals have been seen at knee arthroscopy performed for other purposes (McCarty 1977) . In a needle biopsy and aspiration study of the knee in subjects with quiescent knee gout, Gordon et al. (1982) demonstrated synovial fluid crystals in 85% of patients. In only 2 of their patients had the knee not been involved previously with gout and in both of these MSU crystals were seen in the synovial fluid and were also identified in the single biopsy taken. The present study is the first to investigate systematically the presence of crystals in the knee joint of gouty patients who have never had an acute attack of gout in the knee, a concurrent examination of the synovial fluid from the first toe also being performed.
In previous studies of quiescent first MTP joints (Weinberger et al. 1979 , Rouault et al. 1982 , the frequency of crystal identification was 66% and 70% which agrees fairly well with our figure of 52%.
The relative frequency of acute gout in the great toe compared with the knee is 2.5: 1 (Grahame & Scott 1970) and in our study the relative frequency of crystal identification was 1.5: 1. It is perhaps surprising that Gordon et al. (1982) were able to find a higher frequency of MSU crystals in the knee than had been reported in studies on the synovial fluid obtained from first metatarsophalangeal joints. The discrepancy between the frequency reported in our study and that of Gordon et al. may be explained in part by the fact that the two studies are on different patient groups: their study was on patients with tophaceous gout who had had symptomatic gout of the knee, whereas the present study is on a previously uninvolved knee joint in gout patients. Rouault et al. (1982) reported no correlation between the presence of urate crystals and degree ofcontrol ofhyperuricaemia. In this study, however, a significant difference in serum uric acid was demonstrated between patients with and without crystals. It is not surprising that those patients with higher serum uric acid are more likely to have MSU crystals. However, it is perhaps more important to note that in 4 patients with good control of hyperuricaemia (serum uric acid < 350 ymol/l) MSU crystals were identified.-This is in agreement with previous experience (Scott 1978) and would indicate that urate-lowering treatment does not prevent attacks of gout merely by allowing MSU crystals to dissolve. MSU crystals in synovial fluid are described as being sharp or blunt and may be extracellular or intracellular. There is much discrepancy between reports on the morphology of MSU crystals in acute or quiescent gout (Gordon et al. 1982 , Tiliakos et al. 1980 . In this study we were unable to detect any trend in the distribution of crystal shape, or whether intracellular or extracellular. Indeed, in synovial fluids where many crystals were seen, all forms of crystal morphology were identified. Paul et al. (1983) , describing the transmission electron microscopic appearance of MSU crystals, noted that despite diligent examination no protein-like coating was demonstrated on most crystals but in their sole patient with asymptomatic gout a thick fluffy coating was observed.
There was a marked discrepancy between identifying crystalline material by direct visualization and subsequent histological confirmation. As seen in Figure 1 the crystalline clumps are very small and accurate biopsy is therefore sometimes technically difficult. Also the crystalline clumps appear very superficial, perhaps allowing them to be washed off during processing for microscopic analysis. This study again raises the question of induction of inflammation by crystals. It is generally accepted that it is the presence of monosodium urate crystals which initiate the many mediators of inflammation, including possibly leukotriene B4 (Rae et al. 1982) , Hageman factor (Ginsberg et al. 1980 ) and complement activation via the classical (Hasselbacher 1979) and alternate pathway (Fields et al. 1983 , Doherty et al. 1983 ). However, we have identified patients in whom macroscopic clumps of crystalline material can be seen at sites where there is no evidence of present or preceding acute inflammation. It is evident that factors other than the mere presence of crystals are necessary for induction of inflammation, such as crystal size and shape, protein coating or perhaps constituents of the surrounding fluid.
